Company Filing History:
Years Active: 2021
Title: Innovations in Cancer Treatment by Fatima Khan
Introduction
Fatima Khan is an innovative inventor based in Daegu, South Korea. She has made significant contributions to the field of cancer research through her groundbreaking work on peptides that target CD44v6. Her research aims to inhibit cancer metastasis, providing hope for more effective cancer treatments.
Latest Patents
Fatima Khan holds a patent for her invention titled "Peptides for binding to CD44v6 and use thereof." This invention relates to a peptide that specifically binds to CD44v6, which plays a crucial role in cancer cell migration and metastasis. The peptides, v6Pep-1 and v6Pep-2, were selected for their ability to bind effectively to cells with high expression of the human CD44v6 protein. The invention demonstrates that these peptides can interfere with the binding between c-Met and CD44v6, thereby inhibiting cancer cell migration. Additionally, the peptides exhibit stability in serum, indicating their potential as anticancer treatment agents.
Career Highlights
Fatima Khan is affiliated with the Kyungpook National University Industry-Academic Cooperation Foundation. Her work focuses on developing innovative solutions to combat cancer, showcasing her dedication to advancing medical science.
Collaborations
Fatima collaborates with Byung-Heon Lee, contributing to the research and development of her patented peptides. Their partnership enhances the potential for breakthroughs in cancer treatment.
Conclusion
Fatima Khan's innovative work in developing peptides for cancer treatment highlights her commitment to improving patient outcomes. Her research not only advances scientific knowledge but also offers hope for future cancer therapies.